Article Information
History
- March 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Miranda J. Delahoy, PhD*,1,2,3,†,
- Dawud Ujamaa, MS*,1,2,
- Christopher A. Taylor, PhD1,
- Charisse Cummings, MPH1,2,
- Onika Anglin, MPH1,
- Rachel Holstein, MPH1,2,
- Jennifer Milucky, MSPH1,
- Alissa O’Halloran, MSPH1,2,
- Kadam Patel, MPH1,
- Huong Pham, MPH1,
- Michael Whitaker, MPH1,
- Arthur Reingold, MD4,5,
- Shua J. Chai, MD4,6,
- Nisha B. Alden, MPH7,
- Breanna Kawasaki, MPH7,
- James Meek, MPH8,
- Kimberly Yousey-Hindes, MPH8,
- Evan J. Anderson, MD9,10,11,
- Kyle P. Openo, DrPH9,10,11,
- Andy Weigel, LMSW12,
- Kenzie Teno, MPH12,
- Libby Reeg, MPH13,
- Lauren Leegwater, MPH13,
- Ruth Lynfield, MD14,
- Melissa McMahon, MPH14,
- Susan Ropp, PhD15,
- Dominic Rudin15,
- Alison Muse, MPH16,
- Nancy Spina, MPH16,
- Nancy M. Bennett, MD17,
- Kevin Popham, MPH18,
- Laurie M. Billing, MPH19,
- Eli Shiltz, MPH19,
- Melissa Sutton, MD20,
- Ann Thomas, MD20,
- William Schaffner, MD21,
- H. Keipp Talbot, MD21,
- Melanie T. Crossland, MPH22,
- Keegan McCaffrey23,
- Aron J. Hall, DVM1,
- Erin Burns2,
- Meredith McMorrow, MD1,
- Carrie Reed, DSc2,
- Fiona P. Havers, MD1 and
- Shikha Garg, MD1,2,‡
- 1CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
- 2Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
- 3Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
- 4California Emerging Infections Program, Oakland, California, United States
- 5University of California, Berkeley School of Public Health, Berkeley, California, United States
- 6Career Epidemiology Field Officer Program, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
- 7Colorado Department of Public Health and Environment, Denver, Colorado, United States
- 8Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, United States
- 9Emory University School of Medicine, Atlanta, Georgia, United States
- 10Georgia Emerging Infections Program, Georgia Department of Health, Atlanta, Georgia, United States
- 11Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, United States
- 12Iowa Department of Health, Des Moines, Iowa, United States
- 13Michigan Department of Health and Human Services, Lansing, Michigan, United States
- 14Minnesota Department of Health, Saint Paul, Minnesota, United States
- 15New Mexico Emerging Infections Program, New Mexico Department of Health, Santa Fe, New Mexico, United States
- 16New York State Department of Health, Albany, New York, United States
- 17University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
- 18Rochester Emerging Infections Program, University of Rochester Medical Center, Rochester, New York, United States
- 19Ohio Department of Health, Columbus, Ohio, United States
- 20Public Health Division, Oregon Health Authority, Salem, Oregon, United States
- 21Vanderbilt University Medical Center, Nashville, Tennessee, United States
- 22Salt Lake County Health Department, Salt Lake City, Utah, United States
- 23Utah Department of Health, Salt Lake City, Utah, United States
- ↵†Corresponding author:
Miranda J. Delahoy, Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd. MS H24-7, Atlanta, Georgia 30329, United States; email: vuo0{at}cdc.gov. - ↵‡Alternative corresponding authors:
Shikha Garg, Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd. MS H24-7, Atlanta, Georgia 30329, United States; email: izj7{at}cdc.gov.
↵* Miranda J. Delahoy and Dawud Ujamaa contributed equally to this manuscript.